Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 2—February 2008

Streptococcus pneumoniae Serotype 19A in Children, South Korea

Eun Hwa Choi*†, So Hee Kim*, Byung Wook Eun*, Sun Jung Kim†, Nam Hee Kim‡, Hoan Jong Lee*¶Comments to Author , and Jina Lee§Comments to Author 
Author affiliations: *Seoul National University College of Medicine, Seoul, South Korea; †Seoul National University Bundang Hospital, Seongnam, South Korea; ‡Inje University College of Medicine, Goyang, South Korea; §Seoul National University Boramae Hospital, Seoul, South Korea; ¶Seoul National University Hospital, Seoul, South Korea;

Main Article

Table 2

Antimicrobial susceptibility and mef and erm prevalence of serogroup 19 pneumococcal isolates from children in South Korea, 1991–2006, according to sequence type

CC or ST* (no. strains) Serotypes Multidrug resistance† MIC50 (range) in µg/mL for each antimicrobial drug
mef/erm determinants
Penicillin Cefotaxime Erythromycin
CC271-related‡ (116) 19A, 19F Yes 1.5 (1.0–3.0) 1.0 (0.75–4.0) >256 (>256) mef+, erm+
ST1203 (1) 19F No 0.5 0.25 0.5 mef
ST1374 (4) 19A Yes 0.06 (0.04–0.06) 0.12 (0.09–0.12) >256 (>256) mef
ST2394 (1) 19A Yes 1.0 0.5 2.0 mef+, erm
ST2395 (3) 19F Yes 4.0 (4.0) 2.0 (1.0–2.0) 2.0 (2.0) mef+, erm
ST2399 (1) 19F Yes 0.12 0.25 8.0 mef+, erm

*CC, clonal complex; ST, sequence type.
†Resistant to at least 3 antimicrobial drug classes.
‡CC271-related sequence types: ST320 (59 isolates), ST271 (14), ST236 (14), ST283 (7), ST1451 (1), ST1464 (10), ST2395 (3), ST2695 (3), and 1 isolate of each of ST1412, ST1417, ST2396, ST2397, ST2398, ST2694, ST2696, ST2697, and ST2698.

Main Article

Page created: July 08, 2010
Page updated: July 08, 2010
Page reviewed: July 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.